Testing macrolide antibiotics for treating pneumonia in children
Official title: Randomized Controlled Trial of Macrolide Therapy for Mycoplasma pneumoniae
Funded at University of Colorado Denver · NIH-10620551 · Data updated 2026-11-12
This study is looking at whether adding azithromycin to standard antibiotics helps kids in the hospital with Mycoplasma pneumonia, so we can find out the best way to treat them and avoid giving them unnecessary medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | July 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $266,860 |
| NIH project number | 1R34AI174969-01 |
| Project ID | NIH-10620551 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children who are hospitalized with community-acquired pneumonia caused by Mycoplasma pneumoniae.
✕Less likely to help
Patients with pneumonia caused by other pathogens or those not requiring hospitalization may not benefit from this research.
What this research studies
This research investigates the effectiveness of macrolide antibiotics, specifically azithromycin, in treating children hospitalized with Mycoplasma pneumoniae community-acquired pneumonia (CAP). The study will involve randomly assigning participants to receive either a combination of beta-lactam antibiotics and azithromycin or beta-lactam antibiotics with a placebo. By comparing these two groups, the research aims to provide clear evidence on the necessity and effectiveness of macrolide therapy, potentially reducing unnecessary antibiotic use and associated complications in pediatric patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for children suffering from pneumonia, improving recovery rates and reducing hospital stays.
How similar studies have gone: Previous research has shown varying results regarding the effectiveness of macrolides for pneumonia, making this trial a critical step in determining their true benefit in pediatric cases.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Ambroggio, Lilliam — University of Colorado Denver
- Study coordinator: Ambroggio, Lilliam
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.